Tokyo, Sept. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063082) titled 'Impact of erythromycin supply interruption on patients with bronchiectasis' on Sept. 28.
Study Type:
Observational
Primary Sponsor:
Institute - National Hospital Organization Kyoto Medical Center
Condition:
Condition - Non-cystic fibrosis bronchiectasis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the impact of discontinuation of erythromycin or switching to another macrolide due to erythromycin supply interruption on bronchiectasis exacerbations in patients with non-cystic fibrosis bronchiectasis who had received erythromycin for at least 12 mo...